How to Buy Eikon Therapeutics Stock

Eikon Therapeutics Inc

Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States.

Eikon Therapeutics stock last closed at $11.65, up 11.27% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Eikon Therapeutics stock is currently +47.47% from its 52-week low of $7.90, and -33.05% from its 52-week high of $17.40.

As of Aug 18, 2026, there are 54.17M shares of EIKN outstanding. The market cap of EIKN is $631.02M. In the last 24 hours, 744,000 EIKN shares were traded.

How to Buy Eikon Therapeutics Stock

Wondering how to invest in Eikon Therapeutics stock? Here's how.

  1. Choose where to buy Eikon Therapeutics stock: You need to choose an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Eikon Therapeutics stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your brokerage account: Pick your method of payment and add your details.
  4. Evaluate Eikon Therapeutics stock: The Eikon Therapeutics ticker symbol is EIKN. Is Eikon Therapeutics stock a good investment? Should you buy shares of EIKN? How do EIKN's underlying business fundamentals look? Do top analysts think Eikon Therapeutics is a good buy? Why has EIKN's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if EIKN is a good stock to buy).
  5. Execute your EIKN trade: Decide if you will purchase EIKN shares at the current market price or use a limit order to purchase EIKN shares at a given price.
  6. Get key alerts regarding your EIKN position: Create a watchlist to track your new investment in Eikon Therapeutics shares.

Step 1: Choose where to buy Eikon Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy EIKN shares.

A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

In our opinion, eToro is the best place to buy stocks. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen the right brokerage, the next step is to fill out some personal details so you can buy EIKN stock today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to create a new brokerage account.
  1. Submit your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you've finished signing up on the stocks app, your next step is to transfer the money for your investment:

Check out the walkthrough below for more details depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Eikon Therapeutics stock

After you have selected the best place to buy Eikon Therapeutics stock, it's important to analyze their stock prior to buying, so you truly understand the risk as well as the upside.

Eikon Therapeutics shares data

EIKN Price
$11.65
1w %
13.88%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
1.35x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$631.02M
Next Earnings
N/A
Next Dividend
N/A

Eikon Therapeutics Due Diligence Score

WallStreetZen was designed to help average investors perform more accurate fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on EIKN's stock page.

Is EIKN stock undervalued or overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge EIKN's intrinsic value.

Using relative valuations ratios:

  • EIKN could be undervalued based on its P/B ratio of 1.35x, relative to Biotechnology industry P/B ratio of 5.4x

You can do additional valuation research on EIKN's stock here.

Is EIKN a healthy company?

Pros:

  • There are more short-term assets than short-term liabilities on the EIKN balance sheet.
  • There are more short-term assets than long-term liabilities on the EIKN balance sheet.

Cons:

  • EIKN has a relatively high debt to equity ratio of 0.67.

Is Eikon Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 6 Equities analysts who give recommendations on EIKN, the consensus analyst rating on Eikon Therapeutics is a Strong Buy

Please note that analyst ratings are not stock recommendations, nor are they investment advice.

Most Recent EIKN Analyst Ratings

Sean Laaman, a top 22% analyst from Morgan Stanley initiates coverage on EIKN with a strong buy rating and announces their EIKN price target of $32.00, on Mar 2, 2026.

You can dig deeper into what analysts are projecting on the Eikon Therapeutics stock forecast page.

EIKN Technical Indicators

SMA10
10.19
SMA20
9.8
SMA50
10.07
SMA100
10.2
SMA200
N/A
MACD
0.21
MACD Signal
-0.03
MACD Histogram
0.24
RSI
63.32
Stochastic %K
84.09
Stochastic %D
82.35
StochRSI %K
89.35
StochRSI %D
91.39

Are EIKN executives and large shareholders buying or selling the stock?

Over the past 12 months, executives and large shareholders at EIKN have bought more shares than they have sold.

Column Group IV GP LP, 10% Owner of EIKN, was the latest EIKN insider to buy. They bought $25,871,814.00 worth of EIKN shares on Feb 6, 2026.

Dig into more about who owns EIKN stock here.

Can I rely on EIKN as an income stream?

No, Eikon Therapeutics doesn't provide an income stream by paying out dividends.

EIKN Social Trading Data

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Execute your EIKN trade

There are two primary order types:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly sufficient.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a given dollar amount, use a limit order.

Press the Open button and eToro will execute the order.

If you need additional info about investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get key alerts regarding your EIKN position

Now that you own some shares in EIKN, you'll want to keep up with your stock purchase.

Add EIKN to a watchlist to track the most important metrics related to your EIKN stock.

EIKN Feed

How to Buy Stock in Eikon Therapeutics

To reiterate, here are the 6 steps you need to take to buy Eikon Therapeutics stock right now:

  1. Choose where to buy Eikon Therapeutics stock
  2. Sign up for your brokerage account
  3. Put funds into your brokerage account
  4. Evaluate Eikon Therapeutics stock
  5. Execute your EIKN trade
  6. Get key alerts regarding your EIKN position

If you are looking for a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get updates on your investment in Eikon Therapeutics, click the button below.

NASDAQ: EIKN
$11.65+1.18 (+11.27%)
Updated Aug 18, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: EIKN
$11.65+1.18 (+11.27%)
Updated Aug 18, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Eikon Therapeutics share?

As of Aug 18, 2026, it costs $11.65 to buy one share of Eikon Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.429 shares of EIKN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Eikon Therapeutics stock?

According to 6 Wall Street analysts who monitor Eikon Therapeutics, their consensus recommendation is to buy Eikon Therapeutics stock.

What is the best way to buy Eikon Therapeutics stock?

One way to place an order for Eikon Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.